Health & Medicine · Oncology
EACR ecDNA and the Genomic Chaos of Cancer
Part of the EACR ecDNA and the Genomic Chaos of Cancer series →

About & call for papers
Extrachromosomal DNA (ecDNA) has emerged as a major driving force in cancer, promoting intratumoral genetic heterogeneity, elevated oncogene copy number, rapid tumour evolution, and treatment resistance, all resulting in shorter survival for patients with many… Read more
Extrachromosomal DNA (ecDNA) has emerged as a major driving force in cancer, promoting intratumoral genetic heterogeneity, elevated oncogene copy number, rapid tumour evolution, and treatment resistance, all resulting in shorter survival for patients with many different types of cancer.
ecDNA is a genetic, epigenetic, and immunological problem, changing how oncogenes, immunomodulatory genes, and gene regulatory elements are inherited and how they function. Recent recognition of ecDNA’s enabling role as a hallmark of cancer – particularly as it results from and promotes genome instability – has highlighted the critical need to better understand its underlying biology.
Advances in the field are happening rapidly, and this first EACR virtual conference on the topic will address some of the most recent science that promises to transform our understanding of cancer and translate into benefit for patients.
The target audience for this conference is basic and translational scientists and clinicians, senior and young investigators. We welcome and encourage not only scientists currently studying ecDNA, but those interested in learning more about and contributing to the field.
Speakers: Kathy Burns (Dana-Farber Cancer Institute, USA) | James Chen (UTSW, USA) | Isidro Cortes-Ciriano (EMBL-EBI Wellcome Genome Campus, UK) | Anton Henssen (Max Delbruck Centre, Germany) | Mariam Jamal-Hanjani (University College London Cancer Institute, UK) | Nnennaya Kanu (UCL, UK) | Paul Mischel (Stanford University School of Medicine, USA) | Carolin Sauer (VHIO, Spain) | Agnel Sfeir (MSKCC, USA) | Andrea Ventura (MSKCC, USA) | Benjamin Werner (Barts Cancer Institute, UK)
Keywords: cancer research, oncology, extrachromosomal DNA (ecDNA), intratumoral heterogeneity, genetic heterogeneity, oncogene copy number levels, tumour evolution, treatment resistance, cancer epigenetics, cancer immunology, immuno-modulation, cancer hallmarks, cancer models, clinical considerations, cancer biomarkers
Deadlines: Abstract submission deadline: 14 January 2027 Registration deadline: 08 February 2027
Key dates
Add abstract submission closes to calendar
Add registration closes to calendar
Add the conference to calendar
Closing dates are Anywhere on Earth (AoE) unless the organizer stated otherwise.
Similar conferences
Health & Medicine · Oncology
Global Summit on Cancer Research and Novel Drug Development
Health & Medicine · Oncology
Global Summit on Cancer Research and Novel Drug Development

Health & Medicine · Oncology


